Shanghai Pharmaceuticals Holding Co., Ltd. (02607) released the Monthly Return on Movements in Securities for the period ending January 31, 2026. The total authorised share capital remained RMB 3,708,361,809, with 919,072,704 H shares (par value of RMB 1) and 2,789,289,105 A shares (par value of RMB 1), showing no change from the previous month.

No adjustments occurred in the number of issued shares for either H shares or A shares. The public float requirement remained fully satisfied. No repurchases or redemptions of shares were recorded, and the treasury shares balance remained at zero.

The A share option scheme recorded 680,000 outstanding share options at an exercise price of RMB 20.16, with no new issuances or transfers during January 2026. All relevant listing rules and regulatory requirements were confirmed as duly met.